P

Inventor

MARTIN MATTHEW W

US73 patents
⚠️ This page may combine multiple inventors who share the name “MARTIN MATTHEW W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FORMA THERAPEUTICS INC

34 patents
US10112915B2Oct 30, 2018

3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC41 citations99
US10494353B2Dec 3, 2019

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC17 citations98
US10494354B2Dec 3, 2019

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC17 citations98
US10472337B2Nov 12, 2019

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC17 citations98
US10450284B2Oct 22, 2019

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC14 citations98
US10450283B2Oct 22, 2019

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC14 citations98
US10442776B2Oct 15, 2019

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC15 citations98
US10428031B2Oct 1, 2019

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC15 citations98
US10421732B2Sep 24, 2019

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC16 citations98
US10421731B2Sep 24, 2019

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC15 citations98
US10414738B2Sep 17, 2019

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC16 citations98
US10377726B2Aug 13, 2019

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC22 citations98
US10239845B2Mar 26, 2019

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC25 citations98
US10214501B2Feb 26, 2019

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC20 citations98
US10214500B2Feb 26, 2019

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC20 citations98
US10513501B2Dec 24, 2019

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC11 citations93
US10494351B2Dec 3, 2019

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC12 citations93
US10494352B2Dec 3, 2019

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC12 citations93
US10479772B2Nov 19, 2019

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC6 citations93
US10464909B2Nov 5, 2019

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC12 citations93
US10464910B2Nov 5, 2019

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC12 citations93
US10457652B2Oct 29, 2019

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC12 citations93
US10336722B2Jul 2, 2019

Tetrahydroquinoline compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC22 citations93
US9422281B2Aug 23, 2016

Benzopiperazine compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC25 citations93
US9388161B2Jul 12, 2016

Tetrahydroquinoline compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC34 citations93
US10472342B2Nov 12, 2019

Compounds and compositions for inhibition of FASN

FORMA THERAPEUTICS INC4 citations84
US10399951B2Sep 3, 2019

Compounds and compositions for inhibition of FASN

FORMA THERAPEUTICS INC5 citations84
US10266487B2Apr 23, 2019

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

FORMA THERAPEUTICS INC4 citations84
US9745253B2Aug 29, 2017

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

FORMA THERAPEUTICS INC10 citations84
US11111229B2Sep 7, 2021

Tetrahydroquinoline compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC4 citations83
US10611750B2Apr 7, 2020

Tetrahydroquinoline compositions as bet bromodomain inhibitors

FORMA THERAPEUTICS INC7 citations83
US10377769B2Aug 13, 2019

Benzopiperazine compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC10 citations83
US10995078B2May 4, 2021

Compounds and compositions for inhibition of FASN

FORMA THERAPEUTICS INC1 citations73
US10508088B2Dec 17, 2019

Methods using HDAC11 inhibitors

FORMA THERAPEUTICS INC3 citations73

VALO HEALTH INC

6 patents

VALO EARLY DISCOVERY INC

5 patents

AMGEN INC

4 patents

MARTIN MATTHEW W

1 patent

Showing the top 50 of 73 patents by PatentIndex Score.